Isabel Jakobs
Rechtsanwältin (Lawyer), Associated Partner

Dr Isabel Jakobs has extensive experience in product regulatory advisory work and product liability law. She has a particular focus on the life sciences and healthcare industry, advising pharmaceutical and medical device companies, hospitals, biotechnology firms as well as chemical and tobacco corporations. In the area of M&A, she regularly guides clients through complex transactions with a product regulatory dimension — from regulatory due diligence and deal structuring through to post-merger integration. She also advises on a wide range of sophisticated matters, including market access strategies, digitalisation in healthcare, product regulation, product-related environmental law and social security law. Beyond these core sectors, Isabel Jakobs regularly counsels clients across numerous other industries on product compliance matters. She has authored a wealth of publications and serves on the advisory board of the specialist journal "Medizinprodukte Journal" (MPJ). She also lectures regularly on quality management at the University of Kassel and is a frequent speaker on product regulatory topics at national and international conferences.
Distinctions
- Legal 500
Recommended for Health, Product Liability and Litigation
Career
Lectures
- "Quality and Law"; regular guest lecture at the University of Kassel
Publications
- Medizinprodukterecht Nomos Kommentar
- Germany - Liability for Medicinal Products and the Right to Disclosure under German Law" (co-author, in European Pharmaceutical Law Review 2/2018)
- Comment on a decision of Kammergericht Berlin, ruling of 23 May 2016, 20 U 207/15 (co-author, in MPR 2/2018)
- Betreiberspezifische Aspekte der neuen Europäischen Medizinprodukteverordnung (co-author, in GuP 2017)
- Rückruf fehlerhafter Medizinprodukte bei deliktischer Produkthaftung, Dissertationsschrift (PhD thesis), published in „Augsburger Schriften zum Arzneimittel und Medizinprodukterecht"
- Software als Medizinprodukt: Haftungs- und versicherungsrechtliche Aspekte (co-author, in MPR 1/2019)
- Messverfahren von Emissionshöchstwerten bei Zigaretten und Zulässigkeit des Verweises auf (private) ISO-Normen“ (comment on ECJ ruling, February 22, 2022 - C-160/20; in ZfPC 3/2022).
- Doctor A.I.: Künstliche Intelligenz und Medizinprodukte, (in Robotik und Produktion, 21 April 2022)
- Poland: Advertising Medical Devices – The New European and Polish Regulatory Framework (co-author, in CEE Legal Matters, 7 February 2023)
Well
informed
Subscribe to our newsletter now to stay up to date on the latest developments.
Subscribe now

